Leap Therapeutics Stock Momentum Indicators Average Directional Movement Index

LPTX Stock  USD 3.19  0.02  0.63%   
Leap Therapeutics momentum indicators tool provides the execution environment for running the Average Directional Movement Index indicator and other technical functions against Leap Therapeutics. Leap Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of momentum indicators indicators. As with most other technical indicators, the Average Directional Movement Index indicator function is designed to identify and follow existing trends. Momentum indicators of Leap Therapeutics are pattern recognition functions that provide distinct formation on Leap Therapeutics potential trading signals or future price movement. Analysts can use these trading signals to identify current and future trends and trend reversals to provide buy and sell recommendations. Please specify Time Period to run this model.

The output start index for this execution was seventeen with a total number of output elements of fourty-four. The average directional index (ADX) measures the strength of a prevailing trend of Leap Therapeutics and whether movement exists in the market. The ADX is measured on a scale of 0 to 100. A low Leap Therapeutics ADX value usually indicates a non-trending market with low volumes, whereas a cross above 20 may indicate the start of a trend. If the ADX is over 40 and begins to fall, it can indicate the slowdown of a current trend. This indicator can also be used to identify non-trending markets, or a deterioration of an ongoing trend. Although market direction is important in its calculation, the ADX is not a directional indicator

Leap Therapeutics Technical Analysis Modules

Most technical analysis of Leap Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Leap from various momentum indicators to cycle indicators. When you analyze Leap charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Leap Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Leap Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Leap Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Leap Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Leap Therapeutics's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Leap Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Leap Therapeutics, we also check how macroeconomic factors affect Leap Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2023 2024 (projected)
Graham Number36.5716.2315.42
Receivables Turnover1.261.451.38
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Leap Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.163.189.65
Details
Intrinsic
Valuation
LowRealHigh
0.286.7513.22
Details
Naive
Forecast
LowNextHigh
0.063.209.67
Details
4 Analysts
Consensus
LowTargetHigh
16.4718.1020.09
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Leap Therapeutics. Your research has to be compared to or analyzed against Leap Therapeutics' peers to derive any actionable benefits. When done correctly, Leap Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Leap Therapeutics.

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Leap Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Leap Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Leap Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Leap Therapeutics Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Leap Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Leap Stock please use our How to Invest in Leap Therapeutics guide.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for Leap Stock analysis

When running Leap Therapeutics' price analysis, check to measure Leap Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Leap Therapeutics is operating at the current time. Most of Leap Therapeutics' value examination focuses on studying past and present price action to predict the probability of Leap Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Leap Therapeutics' price. Additionally, you may evaluate how the addition of Leap Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Valuation
Check real value of public entities based on technical and fundamental data
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Is Leap Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Leap Therapeutics. If investors know Leap will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Leap Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.98)
Revenue Per Share
0.003
Return On Assets
(0.75)
Return On Equity
(1.37)
The market value of Leap Therapeutics is measured differently than its book value, which is the value of Leap that is recorded on the company's balance sheet. Investors also form their own opinion of Leap Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Leap Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Leap Therapeutics' market value can be influenced by many factors that don't directly affect Leap Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Leap Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Leap Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Leap Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.